Sanofi M&A punt soothes France’s Covid-19 shame aimeedonnellan
Sanofi on Aug. 3 said it had agreed to buy Translate Bio in a deal valuing the U.S. biotechnology company at $3.2 billion.
Sanofi said it would acquire all outstanding shares of Translate Bio, which specialises in so-called messenger RNA treatments, for $38 per share in cash. Sanofi and Translate Bio have been working together since 2018 and joined forces last year to develop a vaccine for Covid-19. They expect interim results for phase 1 and 2 clinical trials in the third quarter.Source: REUTERS/Charles PlatiauRelated Links
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Sanofi to Buy Translate BioBy Kim Richters French healthcare major Sanofi has agreed to acquire Translate Bio Inc. in a deal that gives the mRNA-therapeutics company a total equity...
Consulte Mais informação »
Sanofi Buys U.S. Partner Translate Bio For $3.2 Billion As Pharma Giant Bets Big On mRNA TechI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com
Consulte Mais informação »
Florida and Texas had one-third of all US Covid-19 cases in past week, official saysOne-third of all US Covid-19 cases reported in the past week were in just two states — Florida and Texas, according to Jeff Zients, White House Covid-19 response coordinator. The cases are mainly in areas where vaccination rates remain low, he said.
Consulte Mais informação »
mRNA's Next Chapter Has Nothing to Do With COVID-19 VaccinesMRNA's Next Chapter Has Nothing to Do With COVID-19 Vaccines
Consulte Mais informação »
FDA Authorizes Preventive Use of Regeneron DrugThe U.S. Food and Drug Administration has expanded its emergency use authorization for the antibody cocktail from Regeneron, making it the first preventive therapy authorized for unvaccinated and immunocompromised people in high-risk settings.
Consulte Mais informação »